NCT03022617 A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis Status COMPLETED Phase PHASE4
NCT03022045 A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis Status COMPLETED Phase PHASE3
NCT03018509 Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects Status COMPLETED Phase PHASE1
NCT03007810 Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT03004846 A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03004768 Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT03000075 BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02999698 Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact Status UNKNOWN Phase N/A
NCT02995473 Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis Status COMPLETED Phase PHASE2
NCT02993471 A Study of Ixekizumab in Participants With Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT02985736 Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray Status COMPLETED Phase PHASE4
NCT02983981 Topical Psoriasis Study for Patients Receiving Biologic Therapy Status COMPLETED Phase PHASE4
NCT02978690 Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis Status COMPLETED Phase PHASE1
NCT02970331 A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis Status WITHDRAWN Phase PHASE2
NCT02955693 Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 Status COMPLETED Phase PHASE1
NCT02951533 A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02944630 Psychotherapy for Patients With Psoriasis: Effects in Quality of Life Status UNKNOWN Phase NA